APA način citiranja

Chatfield-Reed, K., Gui, S., O’Neill, W. Q., Teknos, T. N., & Pan, Q. (2019). HPV33+ HNSCC is associated with poor prognosis and has unique genomic and immunologic landscapes. Oral Oncol.

Čikaški stil citiranja

Chatfield-Reed, Kate, Shanying Gui, Wendi Q. O’Neill, Theodoros N. Teknos, i Quintin Pan. "HPV33+ HNSCC Is Associated With Poor Prognosis and Has Unique Genomic and Immunologic Landscapes." Oral Oncol 2019.

MLA način citiranja

Chatfield-Reed, Kate, et al. "HPV33+ HNSCC Is Associated With Poor Prognosis and Has Unique Genomic and Immunologic Landscapes." Oral Oncol 2019.